首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   157553篇
  免费   32818篇
  国内免费   2441篇
耳鼻咽喉   5260篇
儿科学   5497篇
妇产科学   2572篇
基础医学   4046篇
口腔科学   1711篇
临床医学   27213篇
内科学   49450篇
皮肤病学   7531篇
神经病学   15731篇
特种医学   6585篇
外科学   41942篇
综合类   252篇
现状与发展   72篇
一般理论   3篇
预防医学   7325篇
眼科学   3511篇
药学   1557篇
中国医学   20篇
肿瘤学   12534篇
  2024年   516篇
  2023年   4822篇
  2022年   1265篇
  2021年   3284篇
  2020年   6145篇
  2019年   2317篇
  2018年   7561篇
  2017年   7489篇
  2016年   8584篇
  2015年   8592篇
  2014年   15737篇
  2013年   16016篇
  2012年   6065篇
  2011年   6085篇
  2010年   10660篇
  2009年   14550篇
  2008年   6356篇
  2007年   4633篇
  2006年   7093篇
  2005年   4324篇
  2004年   3600篇
  2003年   2514篇
  2002年   2538篇
  2001年   3842篇
  2000年   3038篇
  1999年   3235篇
  1998年   3733篇
  1997年   3521篇
  1996年   3426篇
  1995年   3276篇
  1994年   2007篇
  1993年   1617篇
  1992年   1416篇
  1991年   1430篇
  1990年   1089篇
  1989年   1207篇
  1988年   1030篇
  1987年   869篇
  1986年   904篇
  1985年   728篇
  1984年   562篇
  1983年   538篇
  1982年   529篇
  1981年   421篇
  1980年   371篇
  1979年   318篇
  1978年   335篇
  1977年   401篇
  1975年   281篇
  1972年   307篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
82.

Background

Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.

Patients and Methods

We conducted a multicenter retrospective analysis in the Triveneto region of Italy.

Results

One hundred fifty-eight patients received radium 223 in our region. After a median follow-up of 9.5 months, 75 patients died. The median overall survival (OS) was 14.2 months, and the median progression-free survival (PFS) was 6.2 months. Seventy-one (45%) patients achieved progression as best response. Thirty-seven (23%) patients stopped the treatment early because of progression. Eastern Cooperative Oncology Group performance status was prognostic for OS (18.4 vs. 12.3 vs. 7.5 months; 0 vs. 1, P = .0062; 0 vs. 2, P = .0002), whereas previous prostatectomy or docetaxel exposure were not. A neutrophil to lymphocytes ratio ≥ 3 significantly impacted OS (18.1 vs. 9.7 months; P < .001) and slightly impacted PFS (6.6 vs. 5.6 months; P = .05). Patients with a baseline alkaline phosphatase (ALP) value ≥ 220 U/L had worse OS and PFS (24.1 vs. 10.5 months; 7.2 vs. 5.5 months; P < .001). Patients with changes in ALP value achieved better OS (P = .029) and PFS (P = .002). There was no difference according to the line of therapy (0 vs. ≥ 1; P = .490). The main grade 3/4 toxicities were anemia, asthenia, and thrombocytopenia.

Conclusion

This large real-world report confirms comparable OS and PFS data when compared with the pivotal study, as well as the predictive role of ALP and neutrophil to lymphocytes ratio. The definition of the optimal position of radium 223 in the treatment of metastatic castration-resistant prostate cancer has still to be defined.  相似文献   
83.
Marielle Kabbouche MD  FAHS 《Headache》2015,55(10):1426-1429
Status migrainosus is defined by the international classification of headache disorders (ICHD) criteria as a debilitating migraine lasting more then 72 hours. The epidemiology of status migrainosus is still unknown in adult and children, and frequently underdiagnosed. Children and adolescents often end up in the emergency room with an intractable headache that failed outpatient therapy. Six to seven percent of these children do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when patients are affected by a severe intractable headache to prevent further disability and returning the child to baseline activity. Multiple therapies are available for adults and children. Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in children and, along with available therapies for children and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of dihydroergotamine intravenously once patients are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations.  相似文献   
84.
85.
86.
87.
88.
89.
90.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号